anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

219,421-219,480 of 319,975

filter-aware
13
The slide uses two charts to argue that traditional active management is failing to provide alpha, justifying a shift toward alternative strategies.Apollo Global Management | Investor Presentation Deck | 42 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
14
The slide highlights increasing market concentration in the S&P 500 over time.Apollo Global Management | Investor Presentation Deck | 42 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
15
The slide uses a dual-axis chart to show the inverse relationship between bond supply and dealer liquidity, supported by anecdotal evidence of market crashes.Apollo Global Management | Investor Presentation Deck | 42 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
16
The slide uses a stacked bar chart to visualize the transition from traditional 60/40-style allocations to a more diversified structure including private credit and hybrid equity.Apollo Global Management | Investor Presentation Deck | 42 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
17
The slide uses a donut chart to visualize the shift in asset allocation, highlighting the emergence of 'Alternatives' as a major asset class.Apollo Global Management | Investor Presentation Deck | 42 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
18
Uses a visual comparison of two circles to illustrate market expansion potential.Apollo Global Management | Investor Presentation Deck | 42 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
19
Uses the 'March of Progress' evolutionary iconographic metaphor to frame the market shift.Apollo Global Management | Investor Presentation Deck | 42 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
20
The slide uses a process-like diagram to show how Apollo/Athene and 3rd-party investors converge on specific investment vehicles.Apollo Global Management | Investor Presentation Deck | 42 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
21
The slide uses a growth arrow to show progression from simple fund investments to a comprehensive partnership model.Apollo Global Management | Investor Presentation Deck | 42 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
22
Apollo Global Management | Investor Presentation Deck | 42 slidesApollo Global Management | Investor Presentation Deck | 42 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
23
Reflects targets previously communicated at Apollo's Investor Day in October 2021.Apollo Global Management | Investor Presentation Deck | 42 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
24
Includes a disclaimer at the bottom regarding projections.Apollo Global Management | Investor Presentation Deck | 42 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
25
The chart shows historical growth from 2020 to 3Q'23 LTM and a 2026 target.Apollo Global Management | Investor Presentation Deck | 42 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
26
Includes logos of strategic partners: CAIS, iCapital, Figure, and Motive Partners.Apollo Global Management | Investor Presentation Deck | 42 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
27
Apollo Global Management | Investor Presentation Deck | 42 slidesApollo Global Management | Investor Presentation Deck | 42 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
28
The slide uses a simple additive formula (Yield + Hybrid + Equity = Total) to visualize growth targets.Apollo Global Management | Investor Presentation Deck | 42 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
29
The slide uses a series of bar charts to illustrate the components of earnings and their projected doubling.Apollo Global Management | Investor Presentation Deck | 42 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
30
The slide uses a color-coded table to segment business units (Asset Management, Retirement Services, Principal Investing, Other) and track key performance metrics.Apollo Global Management | Investor Presentation Deck | 42 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
31
Apollo Global Management | Investor Presentation Deck | 42 slidesApollo Global Management | Investor Presentation Deck | 42 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
32
The slide uses a three-column layout with distinct color blocks to represent the company's impact pillars.Apollo Global Management | Investor Presentation Deck | 42 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
33
The slide uses a mix of quantitative ESG metrics and qualitative organizational logos to demonstrate social impact.Apollo Global Management | Investor Presentation Deck | 42 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
34
Includes governance principles and leadership team statistics as of September 30, 2023.Apollo Global Management | Investor Presentation Deck | 42 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
35
The slide acts as a navigation hub for team-related content.Apollo Global Management | Investor Presentation Deck | 42 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
36
Apollo Global Management | Investor Presentation Deck | 42 slidesApollo Global Management | Investor Presentation Deck | 42 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
37
Includes detailed footnotes explaining specific adjustments like equity-based profit sharing and merger-related costs.Apollo Global Management | Investor Presentation Deck | 42 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
38
Standard financial disclosure slide found in investor presentations.Apollo Global Management | Investor Presentation Deck | 42 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
39
Page 39 of an Apollo investor presentation.Apollo Global Management | Investor Presentation Deck | 42 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
40
Page number 40 indicates this is part of a larger appendix section.Apollo Global Management | Investor Presentation Deck | 42 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
41
Apollo Global Management | Investor Presentation Deck | 42 slidesApollo Global Management | Investor Presentation Deck | 42 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
42
Page number 42 in the bottom right corner.Apollo Global Management | Investor Presentation Deck | 42 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
01
Slide 1
Arbutus Biopharma | Investor Presentation Deck | 26 slidesArbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Conference presentation Investor relations 1 hit
02
Arbutus Biopharma | Investor Presentation Deck | 26 slidesArbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Conference presentation Investor relations 1 hit
03
Arbutus Biopharma | Investor Presentation Deck | 26 slidesArbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Conference presentation Investor relations 1 hit
04
The slide uses a column-based layout with icons and supporting text to present company strengths.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Conference presentation Investor relations 1 hit
05
The chart uses a Gantt-style visualization to represent clinical trial progress.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Conference presentation Investor relations 1 hit
06
The slide uses a four-column layout to structure the disease overview.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Conference presentation Investor relations 1 hit
07
The slide uses a map to show regional prevalence and a nested circle diagram to show the funnel from total infected to diagnosed to treated.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
08
The slide uses a process-flow diagram to show how different mechanisms of action (NA, RNAi, PD-L1 Inhibitor, Interferon, Vaccines) contribute to the three pillars of the therapeutic approach.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
09
Arbutus Biopharma | Investor Presentation Deck | 26 slidesArbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
10
The slide uses a bulleted list to summarize the therapeutic profile and a diagram to illustrate the mechanism of action targeting HBV transcripts.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Conference presentation Investor relations Beat · ProductLoop · Cost Of Inaction1 hit
11
The slide outlines trial design cohorts (E, F, G, I, J, K) and summarizes findings from parts 1 & 2.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
12
The table displays mean (SE) log10 IU/mL values for various cohorts (E, F, I, J, K, G) from baseline through follow-up week 48.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
13
The slide displays longitudinal data for cohorts E, F, I, J, G, and K, highlighting individual subject responses.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
14
The slide displays 8 individual patient charts tracking biomarker levels over time, with specific annotations for NA retreatment.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
15
Data presented at EASL 2022. Shows longitudinal patient data for patients 42, 43, and 48.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
16
The slide uses a bulleted list format to present key safety findings.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Conference presentation Investor relations 1 hit
17
Arbutus Biopharma | Investor Presentation Deck | 26 slidesArbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Conference presentation Investor relations 1 hit
18
The slide uses a timeline-based process diagram to illustrate the randomization and treatment arms of the clinical trial.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Conference presentation Investor relations 1 hit
19
The slide outlines two distinct treatment arms involving Imdusiran, VTP-300, and Nivolumab.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Conference presentation Investor relations 1 hit
20
The slide details a specific licensing deal with Qilu Pharmaceutical.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Conference presentation Investor relations 1 hit
21
Arbutus Biopharma | Investor Presentation Deck | 26 slidesArbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Conference presentation Investor relations 1 hit
22
The slide uses a three-column layout to explain the scientific basis and therapeutic advantages of the drug candidate.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Conference presentation Investor relations 1 hit
23
The slide shows two distinct experiments: an in vitro T-cell activation assay and an in vivo tumor reduction study.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Conference presentation Investor relations 1 hit
24
The slide outlines a sequential dose-escalation study design.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Conference presentation Investor relations 1 hit
25
The slide uses checkmarks to indicate completed milestones.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Conference presentation Investor relations Beat · Financials1 hit
26
Arbutus Biopharma | Investor Presentation Deck | 26 slidesArbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Conference presentation Investor relations 1 hit
01
Slide 1
argenx SE | Investor Presentation Deck | 25 slidesargenx SE | Investor Presentation Deck | 25 slides · argenx
Conference presentation Investor relations 1 hit
02
argenx SE | Investor Presentation Deck | 25 slidesargenx SE | Investor Presentation Deck | 25 slides · argenx
Conference presentation Investor relations 1 hit
03
The slide uses a background image of a sea with a network-like overlay, reinforcing the 'connected' or 'scientific' theme.argenx SE | Investor Presentation Deck | 25 slides · argenx
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
04
argenx SE | Investor Presentation Deck | 25 slidesargenx SE | Investor Presentation Deck | 25 slides · argenx
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit